Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98


Features associated with successful recruitment of diverse patients onto cancer clinical trials: report from the American College of Surgeons Oncology Group.

Diehl KM, Green EM, Weinberg A, Frederick WA, Holmes DR, Green B, Morris A, Kuerer HM, Beltran RA, Mendez J, Gines V, Ota DM, Nelson H, Newman LA.

Ann Surg Oncol. 2011 Dec;18(13):3544-50. doi: 10.1245/s10434-011-1818-9. Epub 2011 Jun 17.


A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group.

Newman LA, Hurd T, Leitch M, Kuerer HM, Diehl K, Lucci A, Giuliano A, Hunt KK, Putnam W, Wells SA.

J Am Coll Surg. 2004 Oct;199(4):644-51.


Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee.

Newman LA, Lee CT, Parekh LP, Stewart AK, Thomas CR Jr, Beltran RA, Lucci A, Green B, Ota D, Nelson H; American College of Surgeons Oncology Group (ACOSOG) Special Population Committee.

Cancer. 2006 Jan 1;106(1):188-95.


Surgeons: A Future Role in Clinical Trials?

Rusch VW.

Oncologist. 1997;2(3):V-VI.


Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancer.

Leitch AM, Beitsch PD, McCall LM, Posther K, Newman LA, Herndon JE 2nd, Hunt KK, Giuliano AE.

Am J Surg. 2005 Oct;190(4):539-42.


How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials.

Sateren WB, Trimble EL, Abrams J, Brawley O, Breen N, Ford L, McCabe M, Kaplan R, Smith M, Ungerleider R, Christian MC.

J Clin Oncol. 2002 Apr 15;20(8):2109-17.


Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.

Albain KS, Unger JM, Crowley JJ, Coltman CA Jr, Hershman DL.

J Natl Cancer Inst. 2009 Jul 15;101(14):984-92. doi: 10.1093/jnci/djp175. Epub 2009 Jul 7.


Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial.

Duda C, Mahon I, Chen MH, Snyder B, Barr R, Chiles C, Falk R, Fishman EK, Gemmel D, Goldin JG, Brown K, Munden RF, Vydareny K, Aberle DR.

Clin Trials. 2011 Apr;8(2):214-23. doi: 10.1177/1740774510396742. Epub 2011 Jan 17.


The future of surgical research: the role of the American College of Surgeons Oncology Group.

Posther KE, Wells SA Jr.

Eur J Surg Oncol. 2005 Aug;31(6):695-701. Epub 2005 Apr 26. Review.


National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene trial: advancing the science of recruitment and breast cancer risk assessment in minority communities.

McCaskill-Stevens W, Wilson JW, Cook ED, Edwards CL, Gibson RV, McElwain DL, Figueroa-Moseley CD, Paskett ED, Roberson NL, Wickerham DL, Wolmark N.

Clin Trials. 2013 Apr;10(2):280-91. doi: 10.1177/1740774512470315. Epub 2013 Jan 18.


Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Cruz-Flores S, Rabinstein A, Biller J, Elkind MS, Griffith P, Gorelick PB, Howard G, Leira EC, Morgenstern LB, Ovbiagele B, Peterson E, Rosamond W, Trimble B, Valderrama AL; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Epidemiology and Prevention; Council on Quality of Care and Outcomes Research.

Stroke. 2011 Jul;42(7):2091-116. doi: 10.1161/STR.0b013e3182213e24. Epub 2011 May 26.


Clinical trial participation. Viewpoints from racial/ethnic groups.

Roberson NL.

Cancer. 1994 Nov 1;74(9 Suppl):2687-91.


Impact of supplemental site grants to increase African American accrual for the Selenium and Vitamin E Cancer Prevention Trial.

Cook ED, Arnold KB, Hermos JA, McCaskill-Stevens W, Moody-Thomas S, Probstfield JL, Hamilton SJ, Campbell RD, Anderson KB, Minasian LM.

Clin Trials. 2010 Feb;7(1):90-9. doi: 10.1177/1740774509357227.


Recruiting Chinese Americans into cancer screening intervention trials: strategies and outcomes.

Wang JH, Sheppard VB, Liang W, Ma GX, Maxwell AE.

Clin Trials. 2014 Apr;11(2):167-77. doi: 10.1177/1740774513518849. Epub 2014 Feb 24.


Access to Children's Oncology Group and Pediatric Brain Tumor Consortium phase 1 clinical trials: Racial/ethnic dissimilarities in participation.

Nooka AK, Behera M, Lonial S, Dixon MD, Ramalingam SS, Pentz RD.

Cancer. 2016 Oct 15;122(20):3207-3214. doi: 10.1002/cncr.30090. Epub 2016 Jul 12.


Sociodemographic analysis of patients in radiation therapy oncology group clinical trials.

Chamberlain RM, Winter KA, Vijayakumar S, Porter AT, Roach M 3rd, Streeter O, Cox JD, Bondy ML.

Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):9-15.


Minority participation in randomized controlled trials for obsessive-compulsive disorder.

Williams M, Powers M, Yun YG, Foa E.

J Anxiety Disord. 2010 Mar;24(2):171-7. Review.


Minority recruitment in the prostate cancer prevention trial.

Moinpour CM, Atkinson JO, Thomas SM, Underwood SM, Harvey C, Parzuchowski J, Lovato LC, Ryan AM, Hill MS, Deantoni E, Gritz ER, Thompson IM Jr, Coltman CA Jr.

Ann Epidemiol. 2000 Nov;10(8 Suppl):S85-91.


Barriers to therapeutic clinical trials enrollment: differences between African-American and white cancer patients identified at the time of eligibility assessment.

Penberthy L, Brown R, Wilson-Genderson M, Dahman B, Ginder G, Siminoff LA.

Clin Trials. 2012 Dec;9(6):788-97. doi: 10.1177/1740774512458992. Epub 2012 Oct 2.

Supplemental Content

Support Center